From 5th February 2021, Prime Endoscopy Bristol and Practice Plus Group Hospital - Emersons Green reopened to routine (non-2WW) GP endoscopy referrals. Referrals will be seen in clinical priority order. Please include the results of a coeliac screen, FIT, helicobacter pylori faecal antigen or faecal calprotectin where indicated as this will help with the prioritisation of patients.
As well as new routine GP referrals, community providers will also be working through their own backlogs so waiting times will be longer than offered pre-Covid-19. Please manage patient expectations by explaining that the providers are booking patients in order of clinical priority and that wait times may be long. Please use the appropriate BNSSG standard endoscopy referral form when making referrals (should be embedded in EMIS systems)
2 week wait referrals should continue to be referred directly to the acute providers via existing pathways (direct to test via ICE if possible)
In order to manage demand please consider carefully the need for endoscopy prior to referral. There are British Society of Gastroenterology guidelines (1) that give advice on how to manage the demand for endoscopy and the guidance below may also help.
The Prime endoscopy team have particularly made the following suggestions regards certain presentations where endoscopy may not be required:
Sharing of risk across the system is an important consideration. The following guidance has been put together by local consultants and GPs as a preliminary guide to referrers in managing their patients but may be subject to changes as further national and local pathways are developed.
Please see below for current criteria for 2WW referrals. Referrers should continue to refer patients who have suspected cancer without delay:
If a GP has significant concerns about malignancy but the 2WW criteria are not met then they can still refer via 2WW and use the free text box to indicate why they feel a 2WW referral is warranted. This may include:
However, if on review by a consultant a 2WW referral is not considered necessary the referral may be returned.
If further advice on appropriateness of 2WW referral is required then consider using Advice and Guidance services although please be aware that responses from these services may take up to 7 days.
Upper GI endoscopy is an aerosol producing procedure and therefore requires providers to consider carefully the value of an endoscopy before proceeding.
Pre-COVID care pathways may therefore not be appropriate during COVID-19.
Please note that referral for barium swallow should not be considered as an alternative to upper GI endoscopy unless on the advice of a specialist.
Community endoscopy providers are now accepting direct referrals for endoscopy if criteria are met and will prioritise according to clinical need. Please use the standard BNSSG upper GI endoscopy referral form.
Indication for Endoscopy |
Pre-COVID pathway |
Suggested pathway during COVID-19 |
Dyspepsia and reflux (non-2WW) |
Check Upper GI 2WW referral guidelines and refer using this route if appropriate. If there is recent onset dyspepsia in a patient >55 associated with anaemia (1) then refer via 2WW. Use existing dyspepsia and reflux guidelines to guide initial management (including helicobacter pylori stool antigen test and treat if positive) Patients who have no red flags should be maintained on oral treatment and lifestyle advice. If symptoms are still not controlled on oral treatment then consider alternative explanations such as functional dyspepsia. Consider referral to upper GI / gastroenterology/ Prime community GI clinic via eRS for advice on further management. If the advice is to refer for non-2WW endoscopy then please refer for upper GI endoscopy via eRS using the standard BNSSG endoscopy form. Referrals for consideration of surgical management should be made to upper GI surgeons but are likely to be subject to long delays so please manage patient expectation. |
|
Iron deficiency anaemia without red flags |
See Anaemia page. |
Confirm anaemia is due to iron deficiency before considering GI causes. Consider lower GI 2WW indications and/or FIT test and refer appropriately. If lower GI and other causes have been excluded then refer for upper GI endoscopy via eRS using the standard BNSSG endoscopy referral form. |
Acute GI bleed (haematemesis or malena) |
|
Do not refer for routine endoscopy if an acute bleed is suspected. See the Upper GI bleed page. |
Unintended weight loss |
|
Check for other red flags that would indicate a 2WW endoscopy is required. If associated with abdominal pain then consider urgent CT chest/abdo/pelvis rather than referral for endoscopy. If the patient does not have abdominal pain or CT scan is normal, but there are ongoing concerns then refer to gastroenterology advice and guidance via eRS. If the advice is to refer for non-2WW endoscopy then please refer for upper GI endoscopy via eRS using the standard BNSSG endoscopy referral form. |
Persistent nausea or vomiting |
|
If no other red flags and not responding to treatment in primary care then request advice and guidance from gastroenterology or refer to PRIME community gastro clinic. If the advice is to refer for non-2WW endoscopy then please refer for upper GI endoscopy using the standard BNSSG endoscopy referral form. |
Surveillance of Barrett’s oesophagus |
Should be already on surveillance list in secondary care. |
Patients may have their surveillance endoscopy suspended. Please do not refer to expedite as this will not be possible unless there are new or concerning symptoms. If there are new symptoms of dyspepsia that are not controlled by maximal treatment with PPI or dysphagia then refer via upper GI 2WW. Surveillance endoscopy is rarely indicated in patients >75 or with significant frailty or comorbidities who would not do well with surgery. |
Suspected coeliac disease |
See Coeliac disease page of Remedy |
In guidance on restarting endoscopy services the BSG has suggested treating patients (< 55 years) with suspected coeliac disease and a tTG >x10ULN without biopsy. For other patients see detailed advice below: https://www.bsg.org.uk/covid-19-advice/covid-19-specific-non-biopsy-protocol-guidance-for-those-with-suspected-coeliac-disease/ If referral for non-2WW endoscopy is indicated then please refer for upper GI endoscopy via eRS using the standard BNSSG endoscopy referral form for consideration of duodenal biopsy (please warn patients that there may be long waits at his time). |
Family history of upper GI cancer |
If 2 or more first degree relatives have been diagnosed with upper GI cancer then routine endoscopy would normally be suggested. |
Do not refer for endoscopy initially. Obtain detailed family history and refer to gastroenterology via eRS or obtain advice and guidance. If the advice is to refer for non-2WW endoscopy then please refer for upper GI endoscopy via eRS using the standard BNSSG endoscopy referral form. |
|
|
|
Lower GI endoscopy is not an aerosol producing procedure but providers still have reduced capacity to undertake endoscopy due to infection control and PPE guidelines.
Pre-COVID care pathways may therefore not be appropriate during COVID-19.
Referral for barium enema should not be considered as an alternative to lower GI endoscopy unless on the advice of a specialist.
Community endoscopy providers are now accepting direct referrals for endoscopy if criteria are met and will prioritise according to clinical need. Please use the standard BNSSG Lower GI endoscopy referral form.
Indication for Endoscopy |
Pre-COVID pathway |
Suggested pathway during COVID-19 |
Iron deficiency anaemia (non-2WW) |
See Anaemia page on Remedy. Consider FIT test in patients 50 or over and refer via 2WW if positive. |
If FIT negative but ongoing concerns of a GI cause for anaemia then refer to gastroenterology for advice and guidance. If the advice is to refer for non-2WW endoscopy then please refer for lower GI endoscopy via eRS using the standard BNSSG endoscopy referral form. As from 5.10.20 FIT testing has been extended for certain patients who previously met 2WW criteria. See Lower GI 2WW page for details. |
Family history of colorectal cancer |
See FH of colorectal cancer page on Remedy |
Do not refer directly for endoscopy. Existing guidelines apply - take detailed family history and refer to gastroenterology or clinical genetics via eRS. If the advice is to refer for non-2WW endoscopy then please refer refer for lower GI endoscopy via eRS using the standard BNSSG endoscopy referral form. |
Evaluation of abnormality on imaging |
|
If malignancy is considered a possible cause then refer via 2WW pathway. |
Surveillance colonoscopy |
Surveillance colonoscopies are normally arranged by secondary care |
Please do not refer to expedite surveillance colonoscopies as delays are likely and providers will catch up when they can. If a patient develops red flag symptoms then refer via lower GI 2WW. See BSG pathway on Post-polypectomy and Post cancer resection Surveillance (2019) |
Rectal bleeding (non-2WW) |
See Rectal Bleeding page on Remedy. Direct access sigmoidoscopy |
Check Lower GI 2WW page and refer if criteria for 2WW referral are met. If IBD is suspected see section below. Do rectal exam in primary care (and protoscope if possible). Check bloods for iron deficiency anaemia and consider stool for faecal calprotectin. If non-2WW endoscopy is still indicated then please refer for lower GI endoscopy via eRS using the standard BNSSG endoscopy referral form. If referring for treatment of haemorrhoids then ensure that you check the Haemorrhoids page which include a link to the criteria based access funding policy. |
Suspected Inflammatory bowel disease |
Direct access colonoscopy. See IBD page on Remedy. |
If IBD is suspected then check bloods and faecal calprotectin (if possible off NSAIDS /PPI). Do not refer directly for endoscopy. If faecal calprotectin is normal (<100) then IBD Is unlikely – consider other causes (such as irritable bowel syndrome). If faecal calprotectin is raised and minimal symptoms consider repeating the test as up to 50% of repeat tests are normal If faecal calprotectin is raised and patient significantly symptomatic then check guidelines to interpret results and consider referral to IBD clinic via eRS (urgent if indicated) where patients will usually be managed empirically initially. Alternatively, the Prime community GI clinic can see patients who are less likely to have IBD (particularly if symptoms are mild or faecal calprotectin is in 100 -250 range). Patients can be referred via eRS. If non-2WW endoscopy is considered appropriate then please refer for lower GI endoscopy via eRS using the standard BNSSG endoscopy referral form but please be aware that there may be long waits at this time. |
Suspected Irritable bowel syndrome |
See IBS page on Remedy. Endoscopy not usually indicated in low risk patients. |
Refer to IBS guidelines on Remedy and manage in primary care. Do not refer for endoscopy. If symptoms not controlled then consider gastroenterology A and G or refer to community GI clinic (PRIME). If the advice is to refer for non-2WW endoscopy then please refer for lower GI endoscopy via eRS using the standard BNSSG endoscopy referral form. |
|
|
|
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.